Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01274624
Title Study of REOLYSIN; in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oncolytics Biotech
Indications

colon cancer

rectum cancer

Therapies

Fluorouracil + Irinotecan + Leucovorin

Bevacizumab + Pelareorep

Age Groups: adult
Covered Countries USA


No variant requirements are available.